细胞株Cell Lines 100及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV100
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID TA-85B5
AC CVCL_2212
DR DSMZ; ACC-624
CC Doubling time: ~60-70 hours (DSMZ).
CC Breed/subspecies: Wistar-AF/Han.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID Ta288
AC CVCL_6D38
SY T.a 288
RX PubMed=1979317;
CC Characteristics: Infected by Theileria annulaza isolate Ankara.
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID TA3
AC CVCL_4315
DR ChEMBL-Cells; CHEMBL3307258
DR ChEMBL-Targets; CHEMBL613285
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-145.html
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID TA3/Ha
AC CVCL_4321
SY TA3-Ha; TA3 Hauschka
DR CLO; CLO_0009262
DR CLDB; cl4484
DR ECACC; 85061102
RX PubMed=460789;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4315 ! TA3
SX Female
CA Cancer cell line
//
ID TA3/St
AC CVCL_4316
SY TA3-St; TA3 Stockholm
DR TOKU-E; 4019
RX PubMed=460789;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4315 ! TA3
SX Female
CA Cancer cell line
//
ID Ta363
AC CVCL_6D39
RX PubMed=1979317;
CC Characteristics: Infected by Theileria annulaza isolate Ankara.
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID TAB089
AC CVCL_E842
SY TAB
DR dbMHC; 49034
DR ECACC; 88052066
DR IHW; IHW9066
DR IMGT/HLA; 11424
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl66.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TAB1
AC CVCL_GZ67
RX PubMed=12579318;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TAC-1
AC CVCL_3468
DR CLO; CLO_0009263
DR ATCC; CRL-10632
RX Patent=US5093259;
CC Group: Non-human primate cell line.
CC Discontinued: ATCC; CRL-10632; probable.
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Male
CA Cancer cell line
//
ID TAC-2
AC CVCL_G954
SY TAC2; TubuloAlveolar Colony-2
RX PubMed=7768990;
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0075 ! NMuMG
CA Finite cell line
//
ID TaC12
AC CVCL_2G84
SY TaC 12
CC Characteristics: Infected by Theileria annulata.
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID TaD-1
AC CVCL_5635
SY TaD1
DR IFO; IFO50112
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID TaD-1-2
AC CVCL_M863
SY TaD1-2
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5635 ! TaD-1
SX Male
CA Cancer cell line
//
ID TaD-1-3
AC CVCL_5636
SY TaD1-3
DR IFO; IFO50120
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5635 ! TaD-1
SX Male
CA Cancer cell line
//
ID TaD-1-4
AC CVCL_M864
SY TaD1-4
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5635 ! TaD-1
SX Male
CA Cancer cell line
//
ID TaD-1-5
AC CVCL_M865
SY TaD1-5
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5635 ! TaD-1
SX Male
CA Cancer cell line
//
ID TaD-1-6
AC CVCL_M866
SY TaD1-6
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5635 ! TaD-1
SX Male
CA Cancer cell line
//
ID TaD-1-7
AC CVCL_M867
SY TaD1-7
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5635 ! TaD-1
SX Male
CA Cancer cell line
//
ID TaD-1-8
AC CVCL_5637
SY TaD1-8
RX PubMed=2384449;
CC Breed/subspecies: ACI/NM x Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5635 ! TaD-1
SX Male
CA Cancer cell line
//
ID TAD-2
AC CVCL_5370
SY TAD2
DR BTO; BTO:0004770
DR ATCC; CRL-2855
DR BioSample; SAMN03471804
RX PubMed=1973649;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2855; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10,12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,7
ST TPOX: 7,8
ST vWA: 13,16
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Tahr87
AC CVCL_A398
SY TAHR-87; Tahr-87; Tahr 87
DR Cosmic; 999767
DR Cosmic; 1281354
DR Cosmic; 2491092
RX PubMed=7688832;
RX PubMed=9067587;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TAI034
AC CVCL_E843
SY TAI 034
DR dbMHC; 49035
DR ECACC; 94082210
DR IHW; IHW9111
DR IMGT/HLA; 11656
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl111.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TAK3
AC CVCL_2729
DR CLO; CLO_0009264
DR CLDB; cl4485
DR ECACC; 93093004
RX PubMed=6438434;
RX PubMed=6817143;
WW http://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TAKA-1
AC CVCL_T061
RX PubMed=8581919;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Spontaneously immortalized cell line
//
ID Takigawa
AC CVCL_3176
DR BioSample; SAMN03473263
DR CGH-DB; 137-1
DR Cosmic; 1122340
DR Cosmic; 1187296
DR GDSC; 1299066
DR JCRB; JCRB0124
DR JCRB; NIHS0182
CC Discontinued: JCRB; NIHS0182; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 14
ST D16S539: 14
ST D18S51: 22
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 12
ST D8S1179: 10,13
ST FGA: 22
ST Penta D: 12
ST Penta E: 23
ST TH01: 7
ST TPOX: 11
ST vWA: 18
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Tal Jo
AC CVCL_3469
DR CLO; CLO_0009265
DR ATCC; CRL-1267
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TALH SVE.1
AC CVCL_4317
AS CVCL_U960
SY TALH-SVE.1; TALH,SVE.1; TALH; Thick Ascending Limb of Henle's loop
DR BTO; BTO:0004609
RX PubMed=1504097;
RX PubMed=1847303;
RX PubMed=2427348;
RX PubMed=9312212;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID TALL-1
AC CVCL_1736
SY TALL1; T-ALL-1; T-ALL1
DR BTO; BTO:0003739
DR CLO; CLO_0051547
DR BioSample; SAMN03472057
DR BioSample; SAMN03473519
DR CCLE; TALL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308541
DR ChEMBL-Targets; CHEMBL2366254
DR Cosmic; 909762
DR Cosmic; 1375581
DR Cosmic; 1641379
DR Cosmic; 1760534
DR Cosmic; 1760556
DR Cosmic; 2165721
DR Cosmic-CLP; 909762
DR DSMZ; ACC-521
DR GDSC; 909762
DR GEO; GSM887688
DR GEO; GSM888780
DR JCRB; JCRB0086
DR RCB; RCB2084
DR TKG; TKG 0251
RX PubMed=3496132;
RX PubMed=6966589;
RX PubMed=9290701;
RX PubMed=10071127;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=22675565;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; RCB; TKG
ST Amelogenin: X,Y (Cosmic-CLP; DSMZ; JCRB)
ST Amelogenin: X (RCB; TKG)
ST CSF1PO: 11,13
ST D13S317: 8,9
ST D16S539: 9,10
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TALL-101
AC CVCL_4922
DR Cosmic; 721701
DR Cosmic; 913408
DR Cosmic; 933549
DR Cosmic; 1012121
DR Cosmic; 1115586
DR Cosmic; 1151795
DR Cosmic; 1330504
DR Cosmic; 1524824
RX PubMed=1706955;
RX PubMed=2656885;
RX PubMed=2953797;
RX PubMed=3496132;
CC Characteristics: CSF2 dependent.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TALL-103
AC CVCL_4923
RX PubMed=1706955;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103
CC Characteristics: IL3 dependent.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TALL-103/2
AC CVCL_4805
RX PubMed=1706955;
RX PubMed=2246514;
RX PubMed=2351825;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103
CC Characteristics: IL3 dependent.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4923 ! TALL-103
SX Male
CA Cancer cell line
//
ID TALL-103/3
AC CVCL_L799
RX PubMed=1706955;
RX PubMed=2246514;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103
CC Characteristics: IL3 dependent.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4923 ! TALL-103
SX Male
CA Cancer cell line
//
ID TALL-104
AC CVCL_2771
DR BTO; BTO:0003740
DR CLO; CLO_0009267
DR ATCC; CRL-11386
DR BioSample; SAMN03471335
DR CCRID; 3111C0001CCC000167
DR Cosmic; 683541
RX PubMed=1706955;
CC Characteristics: IL2 dependent.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 7,13
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TALL-105
AC CVCL_L800
RX PubMed=1706955;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TALL-106
AC CVCL_L801
RX PubMed=1706955;
CC Characteristics: IL3 dependent.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TALL-107
AC CVCL_8464
RX PubMed=8490180;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TalphaT1
AC CVCL_U355
SY T-alpha-T1
RX PubMed=8898243;
RX PubMed=15541569;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_U463 ! AlphaT1-1
CA Transformed cell line
//
ID TALS9-11.2
AC CVCL_FA04
SY ND50008
DR NHCDR; ND50008
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
CC Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (Mutation in C9orf72).
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID TALS9-12.3
AC CVCL_FA05
SY ND50009
DR NHCDR; ND50009
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID TALS9-8.1
AC CVCL_EZ97
SY ND50002
DR NHCDR; ND50002
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EZ98 ! TALS9-8.6
SX Male
CA Induced pluripotent stem cell
//
ID TALS9-8.6
AC CVCL_EZ98
SY ND50011
DR NHCDR; ND50011
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EZ97 ! TALS9-8.1
SX Male
CA Induced pluripotent stem cell
//
ID TALS9-9.3
AC CVCL_EZ95
SY ND50000
DR NHCDR; ND50000
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EZ96 ! TALS9-9.5
SX Female
CA Induced pluripotent stem cell
//
ID TALS9-9.5
AC CVCL_EZ96
SY ND50001
DR NHCDR; ND50001
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EZ95 ! TALS9-9.3
SX Female
CA Induced pluripotent stem cell
//
ID TALSCTRL11.5
AC CVCL_EZ99
SY ND50003
DR NHCDR; ND50003
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID TALSCTRL15.12
AC CVCL_FA00
SY ND50004
DR NHCDR; ND50004
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID TALSSOD1A4V-39.7
AC CVCL_FA06
SY ND50010
DR NHCDR; ND50010
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
CC Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ala4Val).
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID TALSSPO16.2
AC CVCL_FA01
SY ND50005
DR NHCDR; ND50005
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID TALSSPO21.21
AC CVCL_FA02
SY ND50006
DR NHCDR; ND50006
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID TALSTDP-47.10
AC CVCL_FA03
SY ND50007
DR NHCDR; ND50007
WW http://www.targetals.org/about-us/how_were_organized.html
CC From: Target ALS Foundation; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID Talsky
AC CVCL_DN31
RX PubMed=26842912;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID TAM.T
AC CVCL_4008
DR CLO; CLO_0009268
DR ATCC; CRL-6001
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6001; true.
OX NCBI_TaxID=48850; ! Tamandua tetradactyla
SX Sex undetermined
CA Finite cell line
//
ID TAMH
AC CVCL_B471
DR BTO; BTO:0004226
RX PubMed=7525051;
CC Breed/subspecies: CD-1 MT42 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID Tank
AC CVCL_0E95
SY TANK
DR ATCC; CRL-1847
RX PubMed=1690682;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-1847; true.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID Tanoue
AC CVCL_1852
SY TANOUE
DR CLO; CLO_0009269
DR CLO; CLO_0050979
DR EFO; EFO_0002380
DR BioSample; SAMN03472169
DR BioSample; SAMN03473578
DR Cosmic; 1012122
DR Cosmic; 1130258
DR Cosmic; 1281385
DR DSMZ; ACC-399
DR IGRhCellID; TANOUE
DR RCB; RCB1180
RX PubMed=7538617;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40 hours (DSMZ).
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): DSMZ; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12 (DSMZ)
ST D5S818: 10,11,12 (RCB)
ST D7S820: 10,11
ST TH01: 7,10
ST TPOX: 11
ST vWA: 14,19 (DSMZ)
ST vWA: 14,18,19 (RCB)
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID tao BpRc1
AC CVCL_3800
SY tao BpRcl
DR CLO; CLO_0009270
DR ATCC; CRL-2218
CC Breed/subspecies: C57L.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3492 ! BpRc1
SX Female
CA Cancer cell line
//
ID TAOV
AC CVCL_U987
DR BTO; BTO:0004922
RX PubMed=12019149;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TARL-2
AC CVCL_0557
DR MCCL; MCC:0000458
RX PubMed=2880789;
RX PubMed=6323614;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID TARS-1
AC CVCL_D322
RX PubMed=2880789;
RX PubMed=2892480;
RX PubMed=6323614;
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID TART-1
AC CVCL_D323
RX PubMed=2880789;
RX PubMed=6323614;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID TAS-5
AC CVCL_8484
DR JCRB; JCRB1370
RX PubMed=8660794;
RX PubMed=9893044;
CC Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID TASK1
AC CVCL_3177
DR BioSample; SAMN03470806
DR Cosmic-CLP; 1299067
DR GDSC; 1299067
DR GEO; GSM827197
DR GEO; GSM1670524
DR JCRB; JCRB0139
DR JCRB; NIHS0202
RX PubMed=9661044;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0202; true.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 12
ST D5S818: 13
ST D7S820: 12
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Tat-1
AC CVCL_M789
RX PubMed=11840295;
DI NCIt; C3209; Follicular lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TAT1
AC CVCL_T980
SY TAT-1
DR ECACC; 00020911
RX PubMed=2606940;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Tau RD P301S FRET Biosensor
AC CVCL_DA04
DR ATCC; CRL-3275
RX PubMed=25261551;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID TAW-925
AC CVCL_Z044
RX PubMed=3030301;
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID TAYA
AC CVCL_M717
RX PubMed=11914605;
CC Doubling time: 50 hours (PubMed=11914605).
CC Derived from metastatic site: Ascites.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TB
AC CVCL_4Z67
RX PubMed=10320710;
CC Doubling time: 18 +- 2 hours (PubMed=10320710).
DI NCIt; C6891; Meningeal melanomatosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tb 1 Lu
AC CVCL_2730
SY Tb 1 Lu (NBL-12); NBL-12; TB1 Lu; TB-1 Lu; Tb1.Lu; Tb1Lu; Bat lung
DR CLO; CLO_0009271
DR CLO; CLO_0009272
DR CLO; CLO_0009274
DR CLO; CLO_0009275
DR CLDB; cl392
DR CLDB; cl4486
DR CLDB; cl4487
DR CLDB; cl4488
DR ATCC; CCL-88
DR ATCC; CRL-6564
DR CCLV; CCLV-RIE 0072
DR ECACC; 90020805
DR ICLC; ATL96010
DR IZSLER; BS CL 84
RX PubMed=7065527;
RX PubMed=19941903;
CC Group: Bat cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6564; true.
OX NCBI_TaxID=9438; ! Tadarida brasiliensis
SX Female
CA Finite cell line
//
ID TB 28-2
AC CVCL_F778
DR CLO; CLO_0009273
DR ATCC; HB-61
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID TB-6c
AC CVCL_M351
RX PubMed=226998;
RX PubMed=6267945;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8386; ! Rhinella marina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TB1A2
AC CVCL_1D84
RX PubMed=8691151;
WW http://www.ott.nih.gov/erma/tb1a2-cells-are-defective-protein-tyrosine-kinase-syk-immunoglobulin-ige-receptor-induced
CC Breed/subspecies: Wistar.
DI NCIt; C60428; Rat leukemia
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0591 ! RBL-2H3
CA Cancer cell line
//
ID TB2
AC CVCL_Y570
SY Tilapia Brain 2
RX PubMed=18096421;
CC Group: Fish cell line.
OX NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TBC34836
AC CVCL_V383
DR IMGT/HLA; 14461
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TBC60311
AC CVCL_V384
DR IMGT/HLA; 14460
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID TBCN-1
AC CVCL_0T71
RX PubMed=9824643;
CC Doubling time: 54 hours (PubMed=9824643).
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TBCN-6
AC CVCL_H710
SY TBCN6
RX CelloPub=CLPUB00275;
RX PubMed=15645130;
CC Derived from metastatic site: Liver.
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TBE-1 [Human bronchial epithelial]
AC CVCL_R813
RX PubMed=3975607;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TBE-1 [Turbot]
AC CVCL_R814
SY TurBot Epithelial-1
RX PubMed=8856337;
CC Group: Fish cell line.
OX NCBI_TaxID=52904; ! Scophthalmus maximus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TBJ
AC CVCL_L429
RX PubMed=8749920;
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4343 ! C-1300
SX Male
CA Cancer cell line
//
ID TBK1-DEF
AC CVCL_4W78
DR JCRB; JCRB1535
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID TBL20
AC CVCL_2G83
SY TaH/BL20; TaBL 20
RX PubMed=2421227;
RX PubMed=7770085;
RX PubMed=23840536;
CC Characteristics: In vitro infected by Theileria annulata isolate Hissar.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Holstein Friesian.
DI NCIt; C131469; Bovine leukemia
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_L859 ! BL20
SX Female
CA Cancer cell line
//
ID TBL3
AC CVCL_2G82
SY TaH/BL3
RX PubMed=7770085;
CC Characteristics: In vitro infected by Theileria annulata isolate Hissar.
CC Breed/subspecies: Hereford.
DI NCIt; C131469; Bovine leukemia
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_3454 ! BL-3 [Bovine leukemia]
SX Male
CA Cancer cell line
//
ID TBM-54
AC CVCL_5654
SY TB-M
DR CLO; CLO_0009278
DR ATCC; CRL-2051
RX PubMed=226998;
RX PubMed=6267945;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8386; ! Rhinella marina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID TBR-B
AC CVCL_6A91
SY TBRB
RX PubMed=7796878;
RX PubMed=10996322;
RX PubMed=11520047;
RX PubMed=11776976;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TBR10-1
AC CVCL_F961
SY TBR 10-1; TBR10
DR TKG; TKG 0622
RX PubMed=9638976;
RX PubMed=11776976;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TBR31-1
AC CVCL_5371
SY TBR 31-1
RX CelloPub=CLPUB00291;
RX PubMed=9224657;
RX PubMed=9638976;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6A86 ! TBR31-2
CA Conditionally immortalized cell line
//
ID TBR31-2
AC CVCL_6A86
SY TBR 31-2
RX PubMed=7796878;
RX PubMed=9638976;
RX PubMed=10679225;
RX PubMed=11520047;
RX PubMed=11776976;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5371 ! TBR31-1
CA Conditionally immortalized cell line
//
ID TBR52
AC CVCL_6A92
SY TBR 52
RX PubMed=7796878;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TBR59
AC CVCL_5372
SY TBR 59
RX CelloPub=CLPUB00291;
RX PubMed=7796878;
RX PubMed=9224657;
RX PubMed=9638976;
RX PubMed=10378898;
RX PubMed=11520047;
RX PubMed=17233813;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TBR59
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TC 178
AC CVCL_N709
SY T.C. 178; TC178; Tissue Culture 178
RX CelloPub=CLPUB00278;
RX PubMed=195435;
RX PubMed=467167;
RX PubMed=13766343;
RX PubMed=13856118;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC 224
AC CVCL_N710
RX PubMed=13766343;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC 314
AC CVCL_5H67
SY TC314
RX CelloPub=CLPUB00278;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC 379
AC CVCL_5G75
SY TC379
RX CelloPub=CLPUB00278;
RX PubMed=467167;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC 396
AC CVCL_5G74
RX CelloPub=CLPUB00278;
RX PubMed=467167;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC 491
AC CVCL_5G76
SY TC491
RX PubMed=5578746;
CC Miscellaneous: Cell line has been lost (PubMed=5578746).
CC Derived from metastatic site: Cerebellum.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC 501
AC CVCL_N711
SY TC501
RX CelloPub=CLPUB00278;
RX PubMed=195435;
RX PubMed=467167;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N712 ! TC 526
SX Male
CA Cancer cell line
//
ID TC 526
AC CVCL_N712
SY TC526
RX CelloPub=CLPUB00278;
RX PubMed=195435;
RX PubMed=467167;
RX PubMed=3288483;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_N711 ! TC 501
SX Male
CA Cancer cell line
//
ID TC 593
AC CVCL_N713
SY TC593
RX CelloPub=CLPUB00278;
RX PubMed=195435;
RX PubMed=467167;
RX PubMed=3192213;
RX PubMed=3288483;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC 620
AC CVCL_N714
SY TC-620; TC620
RX CelloPub=CLPUB00278;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=195435;
RX PubMed=467167;
RX PubMed=3142218;
RX PubMed=3192213;
RX PubMed=3288483;
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC 691
AC CVCL_5G73
RX CelloPub=CLPUB00278;
RX PubMed=3288483;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-1 [Human renal carcinoma]
AC CVCL_M349
RX PubMed=1479760;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-1 [Mouse lung]
AC CVCL_4699
SY TC-1[JHU-1]; Tissue Culture-1
DR BTO; BTO:0004795
DR CLO; CLO_0009279
DR ATCC; CRL-2785
DR ATCC; JHU-1
DR NCBI_Iran; C569
RX PubMed=8548765;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Discontinued: ATCC; CRL-2785; true.
CC Discontinued: ATCC; JHU-1; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TC-106
AC CVCL_F531
SY TC106
DR Cosmic; 2228235
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=25010205;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Scalp.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC-131
AC CVCL_7147
SY TC-131T
DR Cosmic; 1091066
RX PubMed=3004699;
RX PubMed=7882340;
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC-135
AC CVCL_9698
SY TC135
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-138
AC CVCL_4Z30
DR Cosmic; 2228236
RX PubMed=25010205;
WW http://www.cogcell.org/cellreqs-eft.php
CC Omics: Deep RNAseq analysis.
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-174
AC CVCL_7148
DR Cosmic; 1091067
RX PubMed=7882340;
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC-205
AC CVCL_4Z31
DR Cosmic; 2228237
RX PubMed=25010205;
WW http://www.cogcell.org/cellreqs-eft.php
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-206
AC CVCL_7149
DR Cosmic; 1091068
RX PubMed=7882340;
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC-212
AC CVCL_S867
SY TC212
RX PubMed=23882450;
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,13
ST D16S539: 11,14
ST D18S51: 12,16
ST D19S433: 13
ST D21S11: 30
ST D2S1338: 19,20
ST D3S1358: 16,18
ST D5S818: 11,13
ST D7S820: 11,12
ST D8S1179: 10,11
ST FGA: 20,24
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC-215
AC CVCL_4Z32
DR Cosmic; 2228238
RX PubMed=25010205;
CC Omics: Deep RNAseq analysis.
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-240
AC CVCL_4Z33
DR Cosmic; 2228239
RX PubMed=25010205;
CC Omics: Deep RNAseq analysis.
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-244
AC CVCL_4Z34
DR Cosmic; 2228240
RX PubMed=25010205;
CC Omics: Deep RNAseq analysis.
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-248
AC CVCL_4Z35
SY TC248
DR Cosmic; 2228241
RX PubMed=25010205;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-249
AC CVCL_4Z36
DR Cosmic; 2228242
RX PubMed=25010205;
CC Omics: Deep RNAseq analysis.
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-252
AC CVCL_S866
SY TC 252; TC252
DR Cosmic; 2060802
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-253
AC CVCL_7150
DR Cosmic; 1091070
DR Cosmic; 2228243
RX PubMed=7882340;
RX PubMed=25010205;
CC Omics: Deep RNAseq analysis.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC-268
AC CVCL_F532
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2841669;
RX PubMed=8577710;
DI NCIt; C3789; Olfactory neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC-280
AC CVCL_S871
CC From: Triche T.J.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC-32
AC CVCL_7151
SY TC32
DR BTO; BTO:0004227
DR CCLE; TC32_BONE
DR Cosmic; 759891
DR Cosmic; 1078387
DR Cosmic; 1084513
DR Cosmic; 1718432
DR Cosmic; 2060803
DR Cosmic; 2228244
DR Cosmic; 2294588
DR GEO; GSM1676322
DR GEO; GSM1701655
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=16631476;
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=25984343;
RX PubMed=26351324;
RX PubMed=28196595;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/TC-32_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 36 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=24312454
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 10,12
ST D16S539: 13,14
ST D18S51: 11,19
ST D19S433: 12,14
ST D21S11: 27,28
ST D2S1338: 17,19
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 12
ST FGA: 23,24
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 15,18
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC-4C
AC CVCL_4Z37
DR Cosmic; 2228245
RX PubMed=25010205;
CC Omics: Deep RNAseq analysis.
DI NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-71
AC CVCL_2213
SY TC71; GM11654
DR BTO; BTO:0002604
DR CLO; CLO_0021329
DR EFO; EFO_0002865
DR BioSample; SAMN03473241
DR CCLE; TC71_BONE
DR Coriell; GM11654
DR Cosmic; 1078383
DR Cosmic; 1082507
DR Cosmic; 1112132
DR Cosmic; 1718433
DR Cosmic; 2228246
DR Cosmic; 2250474
DR Cosmic; 2294589
DR Cosmic-CLP; 1240221
DR DSMZ; ACC-516
DR GDSC; 1240221
DR GEO; GSM510013
DR GEO; GSM887689
DR GEO; GSM888781
DR GEO; GSM1670525
DR GEO; GSM1676323
DR GEO; GSM1701656
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=8617485;
RX PubMed=15150091;
RX PubMed=19787792;
RX PubMed=22460905;
RX PubMed=24312454;
RX PubMed=25010205;
RX PubMed=25223734;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cogcell.org/dl/EFT_Lines_DataSheets/TC-71_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 26 hours (PubMed=25984343); ~24 hours (DSMZ); 21 hours (COG).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): COG; Cosmic-CLP; DSMZ; PubMed=24312454; PubMed=25877200
ST Amelogenin: X,Y (Cosmic-CLP; COG; PubMed=24312454)
ST Amelogenin: X (DSMZ; PubMed=25877200)
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11,14
ST D18S51: 12,15
ST D19S433: 14,16.2
ST D21S11: 29,30
ST D2S1338: 20,24
ST D3S1358: 15,17
ST D5S818: 10
ST D7S820: 10
ST D8S1179: 10,12
ST FGA: 24,26
ST Penta D: 11,14
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17 (COG; DSMZ; PubMed=24312454; PubMed=25877200)
ST vWA: 17,19 (Cosmic-CLP)
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC-78
AC CVCL_Y006
SY TC78
RX PubMed=2474371;
RX PubMed=9177455;
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TC-83
AC CVCL_9716
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC-YIK
AC CVCL_1737
DR CLO; CLO_0050913
DR BioSample; SAMN03472316
DR ChEMBL-Cells; CHEMBL3308250
DR ChEMBL-Targets; CHEMBL2366324
DR Cosmic; 946357
DR Cosmic; 1995659
DR Cosmic-CLP; 946357
DR GDSC; 946357
DR GEO; GSM1670527
DR RCB; RCB0443
RX PubMed=1849445;
RX PubMed=10391092;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 9,11
ST D5S818: 10,11
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C7982; Cervical small cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC1 [Mouse ESC]
AC CVCL_M350
SY TC-1
DR BTO; BTO:0004888
RX PubMed=8601314;
CC Breed/subspecies: 129S6/SvEvTacfBR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID TC1 [Mouse hybridoma]
AC CVCL_G561
SY TC-1
DR ATCC; CRL-2493
RX PubMed=6425217;
CC Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa eta.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TC10
AC CVCL_0558
DR MCCL; MCC:0000459
RX PubMed=8274453;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TC106
AC CVCL_F720
DR IMGT/HLA; 11433
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TC289
AC CVCL_IS68
RX PubMed=11557780;
RX PubMed=16557275;
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TC31
AC CVCL_G562
SY TC-31; TC-31.4
DR ATCC; CRL-2494
RX PubMed=6425217;
CC Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa eta.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TC6
AC CVCL_6A95
SY TC 6; T immortalized chondrocyte-like cell 6
RX PubMed=8915772;
RX PubMed=9224657;
RX PubMed=10502305;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID TC620.6A2
AC CVCL_5G72
RX PubMed=3142218;
RX PubMed=8530186;
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N714 ! TC 620
CA Cancer cell line
//
ID TC7
AC CVCL_S881
DR Cosmic; 711260
DR Cosmic; 887224
RX PubMed=9000572;
RX PubMed=10732766;
RX PubMed=11526487;
RX PubMed=24042735;
CC Microsatellite instability: Instable (MSI) (PubMed=9000572).
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.
ST Source(s): PubMed=24042735
ST Amelogenin: X
ST CSF1PO: 9,14
ST D13S317: 8,10,11
ST D16S539: 10,11
ST D18S51: 16,17,18
ST D19S433: 12,15
ST D21S11: 29,30
ST D2S1338: 21,23
ST D3S1358: 13,17
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 11,12
ST FGA: 21,25
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TC71
AC CVCL_S882
DR Cosmic; 711259
DR Cosmic; 887221
DR Cosmic; 1132567
DR Cosmic; 1479584
RX PubMed=9000572;
RX PubMed=10732766;
RX PubMed=11526487;
RX PubMed=24042735;
CC Microsatellite instability: Instable (MSI) (PubMed=9000572; PubMed=24042735).
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.
ST Source(s): PubMed=24042735
ST Amelogenin: X
ST CSF1PO: 10,15
ST D13S317: 9,12,13
ST D16S539: 11
ST D18S51: 10,11,15
ST D19S433: 13
ST D21S11: 29,32.2
ST D2S1338: 16,17
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 12
ST D8S1179: 10,13
ST FGA: 18,19
ST TH01: 7,8
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Tc81
AC CVCL_Z277
RX PubMed=23535851;
CC Group: Insect cell line.
OX NCBI_TaxID=7070; ! Tribolium castaneum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Tca8113
AC CVCL_6851
SY TCA8113; Tca-8113
DR CCRID; 3111C0001CCC000296
DR CCRID; 3131C0001000700077
DR CCRID; 3142C0001000000067
DR CCRID; 3153C0001000000014
DR Cosmic; 851222
DR KCB; KCB 93034YJ
RX PubMed=3464389;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Tca8113-P160
AC CVCL_7906
SY Tca8113P160
DR CCRID; 3142C0001000000142
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6851 ! Tca8113
SX Female
CA Cancer cell line
//
ID Tca8113-P60
AC CVCL_7907
SY Tca8113P60
DR CCRID; 3142C0001000000141
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6851 ! Tca8113
SX Female
CA Cancer cell line
//
ID Tca8113/CBP [Chengdu]
AC CVCL_9U53
RX PubMed=21365850;
CC Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6851 ! Tca8113
SX Female
CA Cancer cell line
//
ID Tca8113/CBP [Chongqing]
AC CVCL_T058
RX CelloPub=CLPUB00004;
CC Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6851 ! Tca8113
SX Female
CA Cancer cell line
//
ID Tca8113/PYM [Changsha]
AC CVCL_9U54
RX DOI=10.1016/j.cellbi.2008.01.124;
RX PubMed=21040473;
CC Selected for resistance to: ChEBI; CHEBI:78160; Bleomycin A5 (Pingyangmycin).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6851 ! Tca8113
SX Female
CA Cancer cell line
//
ID Tca8113/PYM [Chengdu]
AC CVCL_9U55
RX PubMed=21365850;
CC Selected for resistance to: ChEBI; CHEBI:78160; Bleomycin A5 (Pingyangmycin).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6851 ! Tca8113
SX Female
CA Cancer cell line
//
ID TCAF
AC CVCL_K592
DR ChEMBL-Cells; CHEMBL3307350
DR ChEMBL-Targets; CHEMBL614244
DI NCIt; C3183; T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TCAF-DAX
AC CVCL_K692
SY TCAFDAX
DR ChEMBL-Cells; CHEMBL3307465
DR ChEMBL-Targets; CHEMBL615009
DI NCIt; C3183; T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K592 ! TCAF
CA Cancer cell line
//
ID TCam-2
AC CVCL_T012
SY TCAM-2; TCam 2
DR Cosmic; 1449155
DR Cosmic; 2077183
DR Cosmic; 2163764
RX PubMed=8394948;
RX PubMed=18008088;
RX PubMed=20607849;
RX PubMed=21668453;
RX PubMed=24812411;
DI NCIt; C7328; Testicular seminoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TCC-MESO-1
AC CVCL_E263
RX PubMed=19876922;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E264 ! TCC-MESO-2
SX Male
CA Cancer cell line
//
ID TCC-MESO-2
AC CVCL_E264
RX PubMed=19876922;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E263 ! TCC-MESO-1
SX Male
CA Cancer cell line
//
ID TCC-MESO-3
AC CVCL_E265
RX PubMed=19876922;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TCC-PAN2
AC CVCL_3178
SY TCC-Pan2
DR EFO; EFO_0006764
DR BioSample; SAMN03472903
DR CCLE; TCCPAN2_PANCREAS
DR GEO; GSM887690
DR GEO; GSM888782
DR GEO; GSM1588616
DR JCRB; JCRB1072
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11
ST D18S51: 16
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 8,11
ST D8S1179: 13,16
ST FGA: 20
ST Penta D: 10
ST Penta E: 19
ST TH01: 6,7
ST TPOX: 11,12
ST vWA: 17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TCC-S
AC CVCL_W386
RX PubMed=16130897;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TCCSUP
AC CVCL_1738
SY TCCSuP; TCC-SUP; TCC Sup
DR CLO; CLO_0009283
DR ATCC; HTB-5
DR BioSample; SAMN03472747
DR BioSample; SAMN03473325
DR CCLE; TCCSUP_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3307466
DR ChEMBL-Targets; CHEMBL615010
DR Cosmic; 687459
DR Cosmic; 755398
DR Cosmic; 925833
DR Cosmic; 943734
DR Cosmic; 1046692
DR Cosmic; 1285131
DR Cosmic; 1286003
DR Cosmic; 2037961
DR Cosmic; 2050466
DR Cosmic; 2057460
DR Cosmic; 2444246
DR Cosmic-CLP; 687459
DR DSMZ; ACC-377
DR GDSC; 687459
DR GEO; GSM142308
DR GEO; GSM142311
DR GEO; GSM142312
DR GEO; GSM827282
DR GEO; GSM888783
DR GEO; GSM1374955
DR GEO; GSM1374956
DR GEO; GSM1574563
DR GEO; GSM1670526
RX PubMed=836756;
RX PubMed=3708594;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=6826254;
RX PubMed=22460905;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25984343;
RX PubMed=25997541;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: 46 hours (PubMed=25984343); ~30-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'JCCSUP' in PubMed=6582512.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,14 (ATCC; Cosmic-CLP)
ST D13S317: 11 (DSMZ)
ST D16S539: 9,11
ST D18S51: 15
ST D21S11: 27,31.2
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 13
ST FGA: 21
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TcHMC-1
AC CVCL_H204
RX PubMed=3488124;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID TCL-1
AC CVCL_5373
SY Trophoblast Cell Line-1
RX PubMed=8730883;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=TCL-1
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [ZipSV40-6].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TCL-As
AC CVCL_G008
RX PubMed=6189906;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F909 ! ILT-As
SX Male
CA Transformed cell line
//
ID TCL-Haz
AC CVCL_G009
RX PubMed=6088403;
RX PubMed=6189906;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID TCL-Kan
AC CVCL_G010
DR TKG; TKG 0285
RX PubMed=6088403;
RX PubMed=6189906;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID TCL-Mor
AC CVCL_G011
RX PubMed=6088403;
RX PubMed=6189906;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F910 ! ILT-Mor
OI CVCL_0074 ! TL-Mor
SX Male
CA Transformed cell line
//
ID TCL-Na1
AC CVCL_6852
SY TCL-NA1; TCLNa1; Na1
RX PubMed=2981920;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Na1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID TCL-Ter
AC CVCL_G012
RX PubMed=6189906;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F914 ! ILT-Ter
SX Male
CA Transformed cell line
//
ID TCMK-1
AC CVCL_2772
SY TCMK1; Transformed C3H Mouse Kidney-1
DR BTO; BTO:0004231
DR CLO; CLO_0009284
DR CLDB; cl4493
DR ATCC; CCL-139
DR ECACC; 90050802
DR KCLB; 10139
RX PubMed=14120333;
RX PubMed=14206435;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].
CC Discontinued: ECACC; 90050802; probable.
CC Breed/subspecies: C3H/Mai.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID TCNT1
AC CVCL_K095
DR RCB; AES0127
DR RCB; RCB2701
CC Discontinued: RCB; RCB2701; true.
CC Breed/subspecies: C57BL/6 x 129.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID TCO
AC CVCL_HE32
DR Cosmic; 905004
RX PubMed=7601562;
RX PubMed=15729718;
CC Derived from metastatic site: Not specified.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TCO-1 [Human cervical carcinoma]
AC CVCL_3179
DR BioSample; SAMN03151962
DR ChEMBL-Cells; CHEMBL3308791
DR ChEMBL-Targets; CHEMBL1075599
DR Cosmic; 877475
DR Cosmic; 1152549
DR RCB; RCB0640
RX PubMed=1607768;
RX PubMed=16643607;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a TCS derivative (PubMed=16643607, PubMed=20143388).
CC Discontinued: RCB; RCB0640; true.
DI NCIt; C40187; Cervical keratinizing squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8160 ! TCS
SX Female
CA Cancer cell line
//
ID TCO-1 [Human thyroid carcinoma]
AC CVCL_M839
SY TCO-I
DR BioSample; SAMN03471663
DR CGH-DB; 59-1
DR Cosmic; 909763
DR Cosmic; 2054090
DR GEO; GSM827182
DR JCRB; JCRB0239
RX PubMed=2181436;
RX PubMed=9177455;
RX PubMed=9290701;
RX PubMed=16924234;
RX PubMed=23833040;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 12
ST vWA: 17,19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TCO-2
AC CVCL_3630
DR CLO; CLO_0050920
DR BioSample; SAMN03472216
DR Cosmic; 877476
DR Cosmic; 1152550
DR RCB; RCB0689
RX PubMed=1607768;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 9,12
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,19,20
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TCO-4
AC CVCL_M840
RX PubMed=2181436;
DI NCIt; C4815; Thyroid gland carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID tCPC-12
AC CVCL_0E88
SY tCPC 12; tCPC clone 12
RX PubMed=10973559;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID tCPC-B
AC CVCL_0E89
SY tCPC B; tCPC clone B
RX PubMed=10973559;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID tCPC-C
AC CVCL_0E90
SY tCPC C; tCPC clone C
RX PubMed=10973559;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID tCPC-D
AC CVCL_0E91
SY tCPC D; tCPC clone D
RX PubMed=10973559;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID TCS
AC CVCL_8160
SY TC-S
DR CLO; CLO_0050938
DR BioSample; SAMN03472262
DR RCB; RCB0638
RX PubMed=6520483;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12,13
ST D13S317: 8,10,11
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 11,12,13
ST TH01: 7
ST TPOX: 8,11,12
ST vWA: 14,18,19
DI NCIt; C40187; Cervical keratinizing squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TD
AC CVCL_5M22
RX PubMed=4735239;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_5M20 ! KF
OI CVCL_5M21 ! MB
OI CVCL_5M23 ! WE
CA Cancer cell line
//
ID TD.1
AC CVCL_F779
DR CLO; CLO_0009285
DR ATCC; CRL-2232
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID TDL-1
AC CVCL_8428
DR BioSample; SAMN03151883
RX PubMed=6248453;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453, PubMed=20143388).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2676 ! P3HR-1
SX Male
CA Cancer cell line
//
ID TDL-2
AC CVCL_8429
DR BioSample; SAMN03151884
RX PubMed=6248453;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453, PubMed=20143388).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2676 ! P3HR-1
SX Male
CA Cancer cell line
//
ID TDL-3
AC CVCL_8430
DR BioSample; SAMN03151909
RX PubMed=6248453;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a RPMI-1788 derivative (PubMed=6248453, PubMed=20143388).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2710 ! RPMI-1788
SX Male
CA Transformed cell line
//
ID TDL-4
AC CVCL_8431
DR BioSample; SAMN03151900
RX PubMed=6248453;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Raji derivative (PubMed=6248453, PubMed=20143388).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0511 ! Raji
SX Male
CA Cancer cell line
//
ID TDMM1
AC CVCL_GS49
RX PubMed=15160996;
CC From: Takahashi; Japanese Red Cross Medical Center; Tokyo; Japan.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID TE 112.T
AC CVCL_S335
DR ATCC; CRL-7742
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7742; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Undefined cell line type
//
ID TE 114.T
AC CVCL_S336
DR ATCC; CRL-7743
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7743; true.
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 115.T
AC CVCL_1739
DR CLO; CLO_0009288
DR ATCC; CRL-7744
DR BioSample; SAMN03471144
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID TE 125.T
AC CVCL_1740
DR CLO; CLO_0009289
DR ATCC; CRL-7945
DR ATCC; CRL-7945_FL
DR CCLE; TE125T_SOFT_TISSUE
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7945; true.
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 127.T
AC CVCL_S337
DR ATCC; CRL-7745
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7745; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Undefined cell line type
//
ID TE 130.T
AC CVCL_1741
DR CLO; CLO_0009290
DR ATCC; CRL-7746
DR BioSample; SAMN03471145
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13,14
ST D16S539: 11
ST D5S818: 12
ST D7S820: 10,13
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C99055; Sacrococcygeal teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 131.T
AC CVCL_S338
DR ATCC; CRL-7747
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7747; true.
DI NCIt; C3211; Non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 138.T
AC CVCL_S262
DR ATCC; CRL-7946
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7946; true.
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 139.T
AC CVCL_S339
DR ATCC; CRL-7748
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7748; true.
DI NCIt; C3403; Teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 141.T
AC CVCL_S340
DR ATCC; CRL-7749
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7749; true.
DI NCIt; C3017; Ependymoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 143.T
AC CVCL_S341
DR ATCC; CRL-7750
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7750; true.
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 149.T
AC CVCL_1742
DR CLO; CLO_0009291
DR ATCC; CRL-7751
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7751; true.
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 159.T
AC CVCL_1743
SY TE-159-T
DR CLO; CLO_0009292
DR ATCC; CRL-7752
DR BioSample; SAMN03471147
DR CCLE; TE159T_SOFT_TISSUE
DR Cosmic; 686755
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12,14
ST D16S539: 9,11
ST D5S818: 9,11
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 161.T
AC CVCL_1744
SY TE-161-T
DR CLO; CLO_0009293
DR ATCC; CRL-7753
DR BioSample; SAMN03471146
DR Cosmic; 909765
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7753; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 8,11
ST D5S818: 12,13
ST D7S820: 8
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 170.M
AC CVCL_1745
DR CLO; CLO_0009294
DR ATCC; CRL-7754
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7754; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID TE 175.T
AC CVCL_1746
SY TE-175-T
DR CLO; CLO_0009295
DR ATCC; CRL-7755
DR Cosmic; 683662
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7755; true.
DI NCIt; C3211; Non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 189.T
AC CVCL_S261
DR ATCC; CRL-7947
DR BioSample; SAMN03471128
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7947; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 193.T
AC CVCL_S403
DR ATCC; CRL-7756
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7756; true.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 199.T
AC CVCL_1747
DR CLO; CLO_0009296
DR ATCC; CRL-7757
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7757; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Undefined cell line type
//
ID TE 206.T
AC CVCL_1748
SY TE-206-T
DR CLO; CLO_0009297
DR ATCC; CRL-7758
DR Cosmic; 688124
DR Cosmic; 909766
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7758; true.
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 210.T
AC CVCL_N531
DR ATCC; CRL-7759
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7759; true.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 211.T
AC CVCL_N532
DR ATCC; CRL-7760
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7760; true.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 353.Sk
AC CVCL_1749
SY TE 353.SK
DR BTO; BTO:0005290
DR CLO; CLO_0009298
DR ATCC; CRL-7761
DR BioSample; SAMN03471149
RX PubMed=21517135;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 11,14
ST D16S539: 12
ST D5S818: 10,13
ST D7S820: 10
ST TH01: 6
ST TPOX: 8,12
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1750 ! TE 354.T
SX Female
CA Finite cell line
//
ID TE 354.T
AC CVCL_1750
SY TE354.T; TE354T
DR CLO; CLO_0009299
DR ATCC; CRL-7762
DR BCRJ; 0290
RX PubMed=21517135;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: BCRJ; 0290; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 11,14
ST D16S539: 12
ST D5S818: 10,13
ST D7S820: 10
ST TH01: 6
ST TPOX: 8,12
ST vWA: 14,17
DI NCIt; C2921; Skin basal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1749 ! TE 353.Sk
SX Female
CA Cancer cell line
//
ID TE 381.T
AC CVCL_1751
SY TE-381-T; TE381T; RD114-B
DR CLO; CLO_0009300
DR ATCC; CRL-7763
DR Cosmic; 1309332
DR IGRhCellID; TE381T
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 10,11
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 9.3
ST TPOX: 9
ST vWA: 18
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 415.T
AC CVCL_N279
DR ATCC; CRL-7764
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7764; true.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 417.T
AC CVCL_1752
DR CLO; CLO_0009301
DR ATCC; CRL-7765
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7765; true.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 418.T
AC CVCL_1753
DR CLO; CLO_0009302
DR ATCC; CRL-7766
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7766; true.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 441.T
AC CVCL_1754
SY TE-441-T
DR CLO; CLO_0009303
DR ATCC; CRL-7767
DR BioSample; SAMN03471150
DR CCLE; TE441T_SOFT_TISSUE
DR ChEMBL-Cells; CHEMBL3308304
DR ChEMBL-Targets; CHEMBL2366268
DR Cosmic; 687966
DR Cosmic; 924248
DR Cosmic; 1309327
DR Cosmic-CLP; 924248
DR GDSC; 924248
DR GEO; GSM887696
DR GEO; GSM888789
DR GEO; GSM1670534
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 7,8
ST vWA: 15,16
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 449.T
AC CVCL_N603
DR ATCC; CRL-7948
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7948; true.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 453.T
AC CVCL_S397
DR ATCC; CRL-7768
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7768; true.
DI NCIt; C3017; Ependymoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 491.T
AC CVCL_S395
DR ATCC; CRL-7769
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7769; true.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 501.T
AC CVCL_S394
DR ATCC; CRL-7770
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7770; true.
DI NCIt; C3167; Acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 543.T
AC CVCL_S396
DR ATCC; CRL-7771
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7771; true.
DI NCIt; C3211; Non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 567.T
AC CVCL_S404
DR ATCC; CRL-7772
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7772; true.
DI NCIt; C99055; Sacrococcygeal teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 585.T
AC CVCL_S260
DR ATCC; CRL-7949
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7949; true.
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 596.T
AC CVCL_S259
DR ATCC; CRL-7950
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7950; true.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE 615.T
AC CVCL_S098
DR ATCC; CRL-7773
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7773; true.
DI NCIt; C3790; Ganglioneuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 617.T
AC CVCL_1755
SY TE-617-T; TE617T
DR CLO; CLO_0009304
DR ATCC; CRL-7774
DR BioSample; SAMN03471151
DR CCLE; TE617T_SOFT_TISSUE
DR Cosmic; 1309328
DR GEO; GSM219749
DR GEO; GSM887699
DR GEO; GSM888792
RX PubMed=19235922;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7774; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 13
ST D5S818: 9,13
ST D7S820: 9,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 671
AC CVCL_1756
SY TE-671; TE671; TE671/RD
DR BTO; BTO:0002605
DR CLO; CLO_0009305
DR CLO; CLO_0009317
DR CLDB; cl4495
DR CLDB; cl4496
DR CLDB; cl4497
DR ATCC; HTB-139
DR BioSample; SAMN03151901
DR ChEMBL-Cells; CHEMBL3307468
DR ChEMBL-Targets; CHEMBL615012
DR CLS; 300355/p805_TE-671
DR Cosmic; 970091
DR DSMZ; ACC-263
DR ECACC; 89071904
DR IZSLER; BS TCL 64
DR NCBI_Iran; C436
RX PubMed=892931;
RX PubMed=2650908;
RX PubMed=2911385;
RX PubMed=2739733;
RX PubMed=20143388;
RX PubMed=24335698;
WW http://www.atcc.org/support/faqs/261cb/TE671%20ATCC%20HTB139-1062.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a RD derivative (PubMed=2650908, PubMed=2739733, PubMed=2911385, PubMed=20143388).
CC Doubling time: ~70-80 hours (DSMZ).
CC Discontinued: ATCC; HTB-139; true.
CC Discontinued: ECACC; 89071904; true.
ST Source(s): ATCC; CLS; DSMZ; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 10,11
ST D18S51: 13
ST D21S11: 28,29
ST D3S1358: 15,17
ST D5S818: 10,11
ST D7S820: 8,12
ST D8S1179: 11,15
ST FGA: 20,21
ST Penta D: 11,13
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 9
ST vWA: 18
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1649 ! RD
SX Female
CA Cancer cell line
//
ID TE 671 Subline No.2
AC CVCL_2731
SY TE671 Subline No.2; TE671 Subline 2; TE671 Line, subline 2
DR CLO; CLO_0009318
DR CLDB; cl4499
DR CLDB; cl4500
DR ATCC; CRL-8805
DR BioSample; SAMN03151902
DR CCRID; 3111C0001CCC000266
DR ECACC; 94052610
DR ICLC; HTL97021
DR KCLB; 28805
RX Patent=US4789640;
RX PubMed=2911385;
RX PubMed=2739733;
RX PubMed=20143388;
WW http://www.atcc.org/support/faqs/4eecc/TE671%20sub%20line%202%20ATCC%20CRL8805-1063.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733, PubMed=20143388).
CC Discontinued: ECACC; 94052610; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 10,11
ST D5S818: 10,11
ST D7S820: 8,12
ST TH01: 9.3
ST TPOX: 9
ST vWA: 18
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1756 ! TE 671
SX Female
CA Cancer cell line
//
ID TE 76.T
AC CVCL_1757
DR CLO; CLO_0009306
DR ATCC; CRL-7732
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7732; true.
DI NCIt; C99055; Sacrococcygeal teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 79.T
AC CVCL_S333
DR ATCC; CRL-7733
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7733; true.
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 84.T
AC CVCL_1758
DR CLO; CLO_0009307
DR ATCC; CRL-7944
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7944; true.
DI NCIt; C8110; Ovarian teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 86.T
AC CVCL_S334
DR ATCC; CRL-7736
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7736; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Undefined cell line type
//
ID TE 87.T
AC CVCL_N533
DR ATCC; CRL-7737
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7737; true.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 89.T
AC CVCL_N535
SY TE-89
DR ATCC; CRL-7738
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7738; true.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE 90.Sk
AC CVCL_2775
DR CLO; CLO_0009308
DR ATCC; CRL-7739
DR BioSample; SAMN03471143
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Misspelling: 'TE9OSK' in BioSample SAMN03471143.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TE 91.Sk
AC CVCL_2773
DR CLO; CLO_0009309
DR ATCC; CRL-7740
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7740; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID TE 98.T
AC CVCL_2774
DR CLO; CLO_0009310
DR ATCC; CRL-7741
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7741; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Undefined cell line type
//
ID Te Ger
AC CVCL_U793
SY XPKABE
DR ATCC; CRL-1275
CC Discontinued: ATCC; CRL-1275; true.
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Te Jes
AC CVCL_U671
SY XP14BE
DR ATCC; CRL-1311
CC Discontinued: ATCC; CRL-1311; true.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Te Ko
AC CVCL_U669
SY TeKo; XP7BE; XP7 BE; GM02590
DR ATCC; CRL-1200
DR Coriell; GM02590
DR JCRB; KURB1072
CC Discontinued: ATCC; CRL-1200; probable.
CC Discontinued: Coriell; GM02590; probable.
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7359 ! GM02485
SX Female
CA Finite cell line
//
ID TE-1
AC CVCL_1759
SY TE1
DR BTO; BTO:0004601
DR CLO; CLO_0051369
DR BCRJ; 0371
DR BioSample; SAMN03472084
DR CCLE; TE1_OESOPHAGUS
DR CCRID; 3131C0001000700089
DR CGH-DB; 305-1
DR CGH-DB; 9254-4
DR ChEMBL-Cells; CHEMBL3308178
DR ChEMBL-Targets; CHEMBL2366092
DR Cosmic; 730296
DR Cosmic; 735780
DR Cosmic; 753621
DR Cosmic; 801322
DR Cosmic; 923173
DR Cosmic; 926097
DR Cosmic; 983713
DR Cosmic; 1043226
DR Cosmic; 1123318
DR Cosmic; 1612896
DR Cosmic-CLP; 753621
DR GDSC; 753621
DR GEO; GSM301571
DR GEO; GSM887695
DR GEO; GSM888788
DR GEO; GSM1670528
DR KCB; KCB 200737YJ
DR RCB; RCB1894
DR TKG; TKG 0252
RX PubMed=520749;
RX PubMed=1778766;
RX PubMed=2990217;
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28224081;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 60 hours (PubMed=520749).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 12
ST D5S818: 11
ST D7S820: 10,11 (Cosmic-CLP; RCB)
ST D7S820: 11 (TKG)
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE-10
AC CVCL_1760
SY TE10
DR CLO; CLO_0051372
DR BioSample; SAMN03472062
DR CCLE; TE10_OESOPHAGUS
DR CCRID; 3131C0001000700090
DR CGH-DB; 313-1
DR CGH-DB; 9262-4
DR ChEMBL-Cells; CHEMBL3308218
DR ChEMBL-Targets; CHEMBL2366308
DR Cosmic; 730351
DR Cosmic; 753622
DR Cosmic; 735789
DR Cosmic; 923179
DR Cosmic; 926106
DR Cosmic; 947598
DR Cosmic; 983722
DR Cosmic; 1043232
DR Cosmic; 1123327
DR Cosmic; 1571760
DR Cosmic; 1608836
DR Cosmic-CLP; 753622
DR GDSC; 753622
DR GEO; GSM887691
DR GEO; GSM888784
DR GEO; GSM1374957
DR GEO; GSM1670529
DR RCB; RCB2099
DR TKG; TKG 0261
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 30 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 8,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE-11
AC CVCL_1761
SY TE11; Te11
DR CLO; CLO_0051373
DR BioSample; SAMN03472004
DR CCLE; TE11_OESOPHAGUS
DR CCRID; 3131C0001000700091
DR CGH-DB; 314-1
DR CGH-DB; 9263-4
DR ChEMBL-Cells; CHEMBL3308219
DR ChEMBL-Targets; CHEMBL2366166
DR Cosmic; 735827
DR Cosmic; 923180
DR Cosmic; 926107
DR Cosmic; 946354
DR Cosmic; 947599
DR Cosmic; 1043233
DR Cosmic; 1123328
DR Cosmic; 1571761
DR Cosmic-CLP; 946354
DR GDSC; 946354
DR GEO; GSM887692
DR GEO; GSM888785
DR GEO; GSM1670530
DR PRIDE; PXD002486
DR RCB; RCB2100
DR TKG; TKG 0262
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 10
ST D16S539: 10,11
ST D5S818: 8,14
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE-12
AC CVCL_1762
SY TE12
DR BioSample; SAMN03151963
DR ChEMBL-Cells; CHEMBL3308220
DR ChEMBL-Targets; CHEMBL2366278
DR Cosmic; 735790
DR Cosmic; 801329
DR Cosmic; 923181
DR Cosmic; 926108
DR Cosmic; 946356
DR Cosmic; 947600
DR Cosmic; 1043234
DR Cosmic; 1123329
DR Cosmic-CLP; 946356
DR GDSC; 946356
DR GEO; GSM1374958
DR GEO; GSM1670531
DR TKG; TKG 0263
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=17804709;
RX PubMed=20143388;
RX PubMed=27397505;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: TKG; TKG 0263; probable.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 10,13
ST TH01: 9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4455 ! TE-2
OI CVCL_9971 ! TE-3
OI CVCL_9972 ! TE-7
OI CVCL_4463 ! TE-13
SX Male
CA Cancer cell line
//
ID TE-13
AC CVCL_4463
SY TE13
DR BTO; BTO:0004599
DR BioSample; SAMN03151964
DR CGH-DB; 315-1
DR CGH-DB; 9264-4
DR Cosmic; 730362
DR Cosmic; 735791
DR Cosmic; 923182
DR Cosmic; 926109
DR Cosmic; 947601
DR Cosmic; 1043235
DR Cosmic; 1123330
DR Cosmic; 1612899
DR TKG; TKG 0264
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).
CC Discontinued: TKG; TKG 0264; probable.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4455 ! TE-2
OI CVCL_9971 ! TE-3
OI CVCL_9972 ! TE-7
OI CVCL_1762 ! TE-12
SX Male
CA Cancer cell line
//
ID TE-14
AC CVCL_3336
SY TE14
DR CLO; CLO_0051374
DR BioSample; SAMN03472005
DR CCLE; TE14_OESOPHAGUS
DR CGH-DB; 316-1
DR Cosmic; 983723
DR Cosmic; 1043236
DR Cosmic; 1123331
DR GEO; GSM887693
DR GEO; GSM888786
DR RCB; RCB2101
DR TKG; TKG 0265
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 12
ST D5S818: 10
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 19
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE-15
AC CVCL_1763
SY TE15; Te15
DR BTO; BTO:0004598
DR CLO; CLO_0051370
DR BioSample; SAMN03472042
DR CCLE; TE15_OESOPHAGUS
DR CGH-DB; 317-1
DR CGH-DB; 9266-4
DR ChEMBL-Cells; CHEMBL3308221
DR ChEMBL-Targets; CHEMBL2366086
DR Cosmic; 753614
DR Cosmic; 923183
DR Cosmic; 983724
DR Cosmic; 1043237
DR Cosmic; 1123332
DR Cosmic; 1612900
DR Cosmic-CLP; 753614
DR GDSC; 753614
DR GEO; GSM887694
DR GEO; GSM888787
DR GEO; GSM1670532
DR PRIDE; PXD002486
DR RCB; RCB1951
DR TKG; TKG 0266
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 37 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 9
ST D7S820: 11
ST TH01: 7
ST TPOX: 9
ST vWA: 15,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE-2
AC CVCL_4455
SY TE2
DR BTO; BTO:0002866
DR BioSample; SAMN03151965
DR CGH-DB; 306-1
DR CGH-DB; 9255-4
DR ChEMBL-Cells; CHEMBL3307467
DR ChEMBL-Targets; CHEMBL615011
DR Cosmic; 730307
DR Cosmic; 735782
DR Cosmic; 801323
DR Cosmic; 923174
DR Cosmic; 926098
DR Cosmic; 947595
DR Cosmic; 983714
DR Cosmic; 1123319
DR Cosmic; 1612897
DR GEO; GSM301572
DR TKG; TKG 0253
RX PubMed=520749;
RX PubMed=1778766;
RX PubMed=2990217;
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).
CC Doubling time: 72 hours (PubMed=520749).
CC Discontinued: TKG; TKG 0253; probable.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9971 ! TE-3
OI CVCL_9972 ! TE-7
OI CVCL_1762 ! TE-12
OI CVCL_4463 ! TE-13
SX Male
CA Cancer cell line
//
ID TE-3
AC CVCL_9971
SY TE3
DR BioSample; SAMN03151966
DR CGH-DB; 9256-4
DR Cosmic; 730318
DR Cosmic; 735783
DR Cosmic; 801324
DR Cosmic; 923175
DR Cosmic; 926099
DR Cosmic; 932977
DR Cosmic; 947596
DR Cosmic; 983715
DR Cosmic; 1043227
DR Cosmic; 1123320
DR GEO; GSM301573
DR GEO; GSM1374959
DR TKG; TKG 0254
RX PubMed=1778766;
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=17804709;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).
CC Omics: Transcriptome analysis.
CC Discontinued: TKG; TKG 0254; probable.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4455 ! TE-2
OI CVCL_9972 ! TE-7
OI CVCL_1762 ! TE-12
OI CVCL_4463 ! TE-13
SX Male
CA Cancer cell line
//
ID TE-4
AC CVCL_3337
SY TE4
DR CLO; CLO_0051377
DR BioSample; SAMN03472060
DR CCLE; TE4_OESOPHAGUS
DR CGH-DB; 307-1
DR CGH-DB; 9257-4
DR Cosmic; 735828
DR Cosmic; 801325
DR Cosmic; 926100
DR Cosmic; 983716
DR Cosmic; 1123321
DR Cosmic; 1571757
DR Cosmic; 2546865
DR Cosmic-CLP; 1503371
DR GDSC; 1503371
DR GEO; GSM887697
DR GEO; GSM888790
DR GEO; GSM1670533
DR RCB; RCB2097
DR TKG; TKG 0255
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17325662;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9,10
ST D5S818: 10
ST D7S820: 11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE-5
AC CVCL_1764
SY TE5
DR CLO; CLO_0051375
DR BioSample; SAMN03472039
DR CCLE; TE5_OESOPHAGUS
DR CGH-DB; 308-1
DR CGH-DB; 9258-4
DR ChEMBL-Cells; CHEMBL3308179
DR ChEMBL-Targets; CHEMBL2366245
DR Cosmic; 735784
DR Cosmic; 801326
DR Cosmic; 923176
DR Cosmic; 926101
DR Cosmic; 947597
DR Cosmic; 983717
DR Cosmic; 1043228
DR Cosmic; 1123322
DR Cosmic-CLP; 735784
DR GDSC; 735784
DR GEO; GSM887698
DR GEO; GSM888791
DR GEO; GSM1670535
DR RCB; RCB1949
DR TKG; TKG 0256
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28224081;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 10
ST D16S539: 9,10
ST D5S818: 9
ST D7S820: 11
ST TH01: 7
ST TPOX: 11
ST vWA: 16
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID TE-6
AC CVCL_1765
SY TE6
DR BTO; BTO:0002867
DR CLO; CLO_0051376
DR BioSample; SAMN03472040
DR CCLE; TE6_OESOPHAGUS
DR CGH-DB; 309-1
DR CGH-DB; 9259-4
DR ChEMBL-Cells; CHEMBL3308180
DR ChEMBL-Targets; CHEMBL2366144
DR Cosmic; 735785
DR Cosmic; 801327
DR Cosmic; 926102
DR Cosmic; 946355
DR Cosmic; 983718
DR Cosmic; 1123323
DR Cosmic; 1571758
DR Cosmic-CLP; 946355
DR GDSC; 946355
DR GEO; GSM887700
DR GEO; GSM888793
DR GEO; GSM1670536
DR RCB; RCB1950
DR TKG; TKG 0257
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 9,10
ST D5S818: 10,13
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 12
ST vWA: 17,19
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE-6/Hypo
AC CVCL_8325
RX PubMed=21965748;
CC Characteristics: Hypoxia-resistant.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1765 ! TE-6
SX Male
CA Cancer cell line
//
ID TE-7
AC CVCL_9972
SY TE7
DR BioSample; SAMN03151967
DR CGH-DB; 310-1
DR Cosmic; 735786
DR Cosmic; 926103
DR Cosmic; 983719
DR Cosmic; 1043229
DR Cosmic; 1123324
DR Cosmic; 1571759
DR GEO; GSM482500
DR GEO; GSM827183
DR GEO; GSM1374960
DR TKG; TKG 0258
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=16364037;
RX PubMed=17804709;
RX PubMed=20143388;
RX PubMed=23795680;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709, PubMed=20143388).
CC Omics: Transcriptome analysis.
CC Discontinued: TKG; TKG 0258; probable.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4455 ! TE-2
OI CVCL_9971 ! TE-3
OI CVCL_1762 ! TE-12
OI CVCL_4463 ! TE-13
SX Male
CA Cancer cell line
//
ID TE-8
AC CVCL_1766
SY TE8
DR BTO; BTO:0004600
DR CLO; CLO_0051371
DR BioSample; SAMN03472061
DR CCLE; TE8_OESOPHAGUS
DR CGH-DB; 311-1
DR CGH-DB; 9260-4
DR ChEMBL-Cells; CHEMBL3308525
DR ChEMBL-Targets; CHEMBL2366182
DR Cosmic; 730329
DR Cosmic; 753623
DR Cosmic; 735787
DR Cosmic; 801328
DR Cosmic; 923177
DR Cosmic; 926104
DR Cosmic; 983720
DR Cosmic; 1043230
DR Cosmic; 1123325
DR Cosmic; 1612898
DR Cosmic; 2546866
DR Cosmic-CLP; 753623
DR GDSC; 753623
DR GEO; GSM887701
DR GEO; GSM888794
DR GEO; GSM1670537
DR RCB; RCB2098
DR TKG; TKG 0259
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17325662;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28224081;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 9 (Cosmic-CLP)
ST TPOX: 8,9 (RCB; TKG)
ST vWA: 14,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID TE-9
AC CVCL_1767
SY TE9; Te9
DR CLO; CLO_0051379
DR BioSample; SAMN03472053
DR CCLE; TE9_OESOPHAGUS
DR CGH-DB; 312-1
DR CGH-DB; 9261-4
DR ChEMBL-Cells; CHEMBL3308181
DR ChEMBL-Targets; CHEMBL2366147
DR Cosmic; 730340
DR Cosmic; 735788
DR Cosmic; 923178
DR Cosmic; 926105
DR Cosmic; 946353
DR Cosmic; 983721
DR Cosmic; 1043231
DR Cosmic; 1123326
DR Cosmic-CLP; 946353
DR GDSC; 946353
DR GEO; GSM887702
DR GEO; GSM888795
DR GEO; GSM1670538
DR PRIDE; PXD002486
DR RCB; RCB1988
DR TKG; TKG 0260
RX PubMed=8509434;
RX PubMed=9290701;
RX PubMed=15172977;
RX PubMed=17804709;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 25 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 9,13
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
- 公告/新闻
